Copper in urine after stopping Wilson disease therapy
Part of Brain & nervous system, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study is looking at what happens to copper levels in the urine when people with Wilson disease briefly stop their medicine. It may help doctors understand how well your body controls copper without treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have Wilson disease, confirmed by a Leipzig score of 4 or higher.
- You need to have been on Wilson disease treatment for at least 1 year.
- Your liver and kidney function should be stable and within certain limits (your doctor can check this).
- You should not have changed your Wilson disease medication in the last 6 months.
- If you are of childbearing age, you must have a negative pregnancy test before stopping your medicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who already have Wilson disease to understand how the condition changes over time. It may help researchers better predict future symptoms and improve care.
This trial is testing an experimental gene therapy called PM577 that aims to fix the faulty gene causing Wilson disease. It might offer a new treatment option that could reduce or replace the need for daily medications.
This study looks at how copper levels in urine change throughout the day and night in people with Wilson disease. If you take part, you will collect all your urine for 24 hours so researchers can measure copper at different times.
This trial tests a new gene therapy called GC310 that may help treat Wilson disease, a genetic condition that causes copper to build up in the body. The therapy aims to fix the underlying cause, which could improve symptoms and quality of life.
This trial is for people who already have a genetic diagnosis of Wilson disease. It looks at whether specific lab tests and a physical eye finding can help confirm and support the diagnosis.
This trial uses a special PET scan with a copper tracer to see how well gene therapy is working in people with Wilson disease. It may help doctors understand if the treatment is helping your body handle copper properly.
Hear when a new Wilson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.